H5N1 News and Research

Latest H5N1 News and Research

Universal vaccine produces long-lasting immunity against influenza A viruses in mice

Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a study led by Georgia State University.

24 Jan 2018

Bulgaria reports outbreaks of bird flu (avian influenza)

Veterinary authorities in Bulgaria have called for culling of nearly 8,000 ducks according to a food safety agency yesterday after two more regions there have reported avian flu infection. According to the agency a total of four outbreaks of bird flu have been registered in Bulgaria at this time.

5 Nov 2017

New way of producing flu vaccine could provide better protection against infection

A new way of producing the seasonal flu vaccine could speed up the process and provide better protection against infection.

24 Jul 2017

Mutations identified that enable human transmission of avian flu

A systematic mutation analysis has shown that changes in just three amino acids of the avian influenza H7N9 virus receptor binding protein confers specificity for human cells.

16 Jun 2017

Scientists develop easy-to-use diagnostic test that could rapidly detect flu

The threat of a major flu pandemic is a perennial concern. Now scientists have developed a fast and easy-to-use point-of-care diagnostic test that could one day help doctors and hospitals head off the rapid spread of the flu.

10 May 2017

New study reports long-term infectious disease trends in China after SARS outbreak

Following the severe acute respiratory syndrome (SARS) outbreak in 2003, China stepped up its prevention and control methods for all infectious diseases, and rates of infection have levelled off since 2009.

19 Apr 2017

Resurgent outbreak of avian influenza underscores need for control efforts at animal source

A resurgent outbreak of a new strain of avian influenza that can be lethal for humans underscores the need for robust and rapid detection and response systems at animal source.

20 Mar 2017

New research exposes cellular responses linked to bird flu vaccine

New research from Vanderbilt eavesdrops on gene expression in human immune system cells before and after vaccination against bird flu.

19 Jan 2017

Influenza experts examine evolution of avian disease

Few influenza viruses are as widespread and adaptable as avian influenza viruses, and scientists are not entirely sure why.

19 Jan 2017

Scientists discover vaccine-induced antibodies that can counteract varied strains of influenza virus

Scientists have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans.

22 Jul 2016

Computer-assisted methods may help as decision support system to combat Zika virus

Global climate change, international travel, and ineffective vector control programs are aiding the emergence of infectious diseases globally. The currently expanding Zika virus (ZIKV) epidemic is one such problem.

21 Mar 2016

Unlocking H5N1 virus replication: an interview with Martin Blackledge

We were able to show that one small domain of the polymerase, the part that is essential for entry of a piece of the polymerase into the cell nucleus, changes its conformation to allow it to interact with the transporter protein than takes it into the nucleus.

3 Mar 2016

RB announces Zika Relief Package of $1 million to help fight Zika virus outbreak

In response to the global call for urgently needed resources to fight the spread of the Zika virus, RB is announcing a Zika Relief Package of $1 million USD consisting of both cash and product donations that will be made available to health authorities and international NGOs battling the outbreak.

16 Feb 2016

CFDA issues new drug certificate and production license for Sinovac's EV71 vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that the China Food and Drug Administration issued the new drug certificate and production license for its Enterovirus 71 ("EV71") vaccine.

4 Jan 2016

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

In clinical trials, several candidate H7N9 pandemic influenza vaccines made from inactivated viruses have been shown to be safe and to generate an immune response. However, scientists believe for practical use, these potential vaccines would require multiple doses or the addition of adjuvants, which enhance the immune response.

12 Dec 2015

Sinovac gets approval to begin clinical trials on Sabin Inactivated Polio Vaccine candidate

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that the Company has obtained approval to begin human clinical trials on its Sabin Inactivated Polio Vaccine (or "sIPV") candidate.

10 Dec 2015

Study reveals molecular function of protein essential for replication of H5N1 flu virus

An international collaboration of scientists from the CEA, CNRS, University Joseph Fourier, the EMBL and the ILL has revealed the molecular function of a protein essential for replication of H5N1 influenza virus.

10 Dec 2015

Researchers use genomic techniques to show why different strains of Salmonella infect particular animal species

It's called bird flu for a reason. Particular characteristics about the influenza virus known as H5N1 allow it to primarily affect avifauna, though in some worrying cases the disease has been passed to humans.

3 Nov 2015

Australian researchers find a way to boost cross-protective capabilities of influenza A vaccine

Australian researchers have found a way to boost the effectiveness and cross-protective capabilities of an influenza A vaccine by adding a simple component. Published this week in mBio, an online open-access journal of the American Society for Microbiology, the research in mice could lead to better seasonal flu vaccines for humans, and also vaccines that could provide community protection in the early stages of an outbreak of a novel flu virus strain.

28 Oct 2015

Sinovac Dalian receives approval to start human clinical trials of varicella vaccine candidate

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human clinical trials on its varicella vaccine candidate. The clinical trial application for the varicella vaccine was officially accepted by the China Food and Drug Administration in January 2013.

26 Oct 2015

H5N1 News and Research

Latest H5N1 News and Research

Universal vaccine produces long-lasting immunity against influenza A viruses in mice

Bulgaria reports outbreaks of bird flu (avian influenza)

New way of producing flu vaccine could provide better protection against infection

Mutations identified that enable human transmission of avian flu

Scientists develop easy-to-use diagnostic test that could rapidly detect flu

New study reports long-term infectious disease trends in China after SARS outbreak

Resurgent outbreak of avian influenza underscores need for control efforts at animal source

New research exposes cellular responses linked to bird flu vaccine

Influenza experts examine evolution of avian disease

Scientists discover vaccine-induced antibodies that can counteract varied strains of influenza virus

Computer-assisted methods may help as decision support system to combat Zika virus

Unlocking H5N1 virus replication: an interview with Martin Blackledge

RB announces Zika Relief Package of $1 million to help fight Zika virus outbreak

CFDA issues new drug certificate and production license for Sinovac's EV71 vaccine

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

Sinovac gets approval to begin clinical trials on Sabin Inactivated Polio Vaccine candidate

Study reveals molecular function of protein essential for replication of H5N1 flu virus

Researchers use genomic techniques to show why different strains of Salmonella infect particular animal species

Australian researchers find a way to boost cross-protective capabilities of influenza A vaccine

Sinovac Dalian receives approval to start human clinical trials of varicella vaccine candidate

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

H5N1 News and Research

Latest H5N1 News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in